Contact hours available until 3/28/17.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:

Planning Committee: No planning committee member discloses a potential or actual conflict of interest.

Speakers: There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and GAPNA.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number, CEP 5387.

Objectives:
1. Explore treatment approaches and goal-setting for glycemic control for older patients with type 2 diabetes as outlined in the most recent version of the joint American Diabetes Association-European Association for the Study of Diabetes Position Statement.
2. Discuss recently published data demonstrating the potential for GLP1 analogs and DPP IV inhibitors to improve cardiometabolic risk factors (i.e. lipids, BP).
3. Review mechanism of action, effectiveness, and side-effect profile of SGLT2 inhibitors, and new class of agents used for glycemic control in patients with type 2 diabetes.

Tyan Thomas PharmD, BCPS

Appearances